Axiom Investors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,621
| Closed | -$500K | – | 152 |
|
|
2025
Q1 | $500K | Sell |
1,621
-8,419
| -84% | -$2.6M | ﹤0.01% | 133 |
|
|
2024
Q4 | $3.54M | Buy |
10,040
+853
| +9% | +$301K | 0.03% | 117 |
|
|
2024
Q3 | $3.29M | Sell |
9,187
-4,595
| -33% | -$1.65M | 0.03% | 114 |
|
|
2024
Q2 | $4.39M | Buy |
13,782
+868
| +7% | +$277K | 0.04% | 111 |
|
|
2024
Q1 | $2.97M | Buy |
12,914
+4,279
| +50% | +$983K | 0.03% | 121 |
|
|
2023
Q4 | $1.9M | Buy |
8,635
+4,210
| +95% | +$926K | 0.02% | 120 |
|
|
2023
Q3 | $999K | Buy |
4,425
+1,229
| +38% | +$278K | 0.01% | 116 |
|
|
2023
Q2 | $706K | Sell |
3,196
-227
| -7% | -$50.1K | 0.01% | 122 |
|
|
2023
Q1 | $767K | Sell |
3,423
-1,043
| -23% | -$234K | 0.01% | 124 |
|
|
2022
Q4 | $1.24M | Sell |
4,466
-33
| -0.7% | -$9.18K | 0.02% | 112 |
|
|
2022
Q3 | $942K | Sell |
4,499
-4,122
| -48% | -$863K | 0.02% | 116 |
|
|
2022
Q2 | $2.03M | Buy |
8,621
+2,052
| +31% | +$483K | 0.06% | 104 |
|
|
2022
Q1 | $1.18M | Sell |
6,569
-10,029
| -60% | -$1.8M | 0.03% | 109 |
|
|
2021
Q4 | $3.59M | Buy |
16,598
+5,388
| +48% | +$1.16M | 0.07% | 94 |
|
|
2021
Q3 | $2.07M | Sell |
11,210
-13,912
| -55% | -$2.57M | 0.03% | 114 |
|
|
2021
Q2 | $4.51M | Buy |
25,122
+4,300
| +21% | +$771K | 0.07% | 92 |
|
|
2021
Q1 | $3.48M | Buy |
+20,822
| New | +$3.48M | 0.06% | 106 |
|